Channel Therapeutics Corporation
CHRO · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,955 | -$7,381 | -$2,459 | -$595 |
| Dep. & Amort. | $692 | $188 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,799 | $3,959 | $110 | $0 |
| Change in WC | $35 | $2,051 | $641 | -$756 |
| Other Non-Cash | -$363 | $202 | -$163 | $586 |
| Operating Cash Flow | -$5,792 | -$981 | -$1,567 | -$1,593 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $321 | $767 | $400 | $0 |
| Stock Issued | $6,055 | $255 | $0 | $0 |
| Stock Repurch. | -$167 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1,222 | $1,593 |
| Financing Cash Flow | $6,210 | $1,022 | $1,622 | $1,593 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $417 | $41 | $55 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $96 | $55 | $0 | $0 |
| End Cash | $513 | $96 | $55 | $0 |
| Free Cash Flow | -$5,792 | -$981 | -$1,567 | -$1,593 |